先天性甲状腺功能减退症患者的成年期甲状腺结局
这项横断面观察性研究纳入103例经新生儿筛查诊断的成年先天性甲状腺功能减退症(CH)患者,按超声分为甲状腺肿、正常腺体和发育不良三组。发育不良组游离三碘甲状腺原氨酸/游离甲状腺素比值显著降低(0.22);甲状腺肿组结节检出率71%(10/14),且89%(8/9)存在遗传缺陷。结果支持现有指南推荐:激素合成障碍型CH患者应定期接受甲状腺超声检查。
要点
- 发育不良组成年CH患者游离T3/游离T4比值显著降低(0.22)。
- 女性CH患者甲状腺结节检出率14.3%(8/56),高于非CH女性。
- 甲状腺肿组结节检出率71%(10/14),89%(8/9)存在遗传缺陷。
核心结论
- 接受左甲状腺素替代治疗的甲状腺发育不良成年患者存在相对性三碘甲状腺原氨酸缺乏。
- 大多数甲状腺肿型CH成年患者存在遗传性激素合成障碍,且甲状腺结节发生风险高。
- 研究结果支持现行指南推荐:激素合成障碍型CH患者应定期接受甲状腺超声检查。
研究设计与样本
- 横断面观察性研究,纳入1979年后出生、经新生儿筛查诊断的成年CH患者103例,就诊于日本东京Ito医院。
- 根据超声检查结果将患者分为甲状腺肿组、正常腺体组和发育不良组。
- 对60例患者进行了基因分析。
- 比较三组间的甲状腺功能检测结果和甲状腺结节检出比例,并比较56例女性CH患者与168例促甲状腺激素水平匹配的非CH女性。
主要发现
- 发育不良组血清游离三碘甲状腺原氨酸/游离甲状腺素比值显著降低(0.22)。
- 女性CH患者甲状腺结节检出率为14.3%(8/56),高于非CH女性。
- 甲状腺结节在甲状腺肿组检出率最高,为71%(10/14)。
- 甲状腺肿组中89%(8/9)的患者检出遗传缺陷,包括甲状腺球蛋白缺陷33%(3/9)、甲状腺过氧化物酶缺陷33%(3/9)和双氧化酶2缺陷22%(2/9)。
关键数值与推荐
- 发育不良组游离三碘甲状腺原氨酸/游离甲状腺素比值为0.22,显著降低。
- 女性CH患者甲状腺结节检出率14.3%(8/56),非CH女性对照未报告具体检出率。
- 甲状腺肿组甲状腺结节检出率71%(10/14)。
- 甲状腺肿组遗传缺陷检出率89%(8/9),其中甲状腺球蛋白缺陷33%(3/9)、甲状腺过氧化物酶缺陷33%(3/9)、双氧化酶2缺陷22%(2/9)。
临床怎么用
- 研究结果支持现行指南推荐:激素合成障碍型CH患者应定期接受甲状腺超声检查。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Background: More than 40 years have passed since the introduction of newborn screening (NBS) for congenital hypothyroidism (CH), and many early diagnosed patients have reached adulthood. Their thyroid morphology and function have been little studied. This cross-sectional, observational study was conducted to characterize the thyroid morphology and function of adult CH patients diagnosed in the framework of NBS for CH. Methods: A total of 103 adult CH patients born after 1979 were enrolled at Ito Hospital, Tokyo, Japan, and were classified into Goiter, Normal gland, and Dysgenesis groups based on ultrasonographic findings. For 60 patients, genetic analysis was performed. Thyroid function test results and the proportion of patients with thyroid nodules were compared among the three groups and between 56 female CH patients and 168 non-CH women matched for thyrotropin levels. Results: A significantly low serum free triiodothyronine/free thyroxine ratio (0.22) was observed in the Dysgenesis group. Thyroid nodules were detected in 14.3% (8/56) of female CH patients, more frequently than in non-CH women. Thyroid nodules were detected most frequently in the Goiter group (71%, 10/14). Genetic defects were identified in 89% (8/9) of patients belonging to the Goiter group, including thyroglobulin defect (33%, 3/9), thyroid peroxidase defect (33%, 3/9), and dual oxidase 2 defect (22%, 2/9). Conclusions: Our results suggest that adults with thyroid dysgenesis on levothyroxine replacement therapy have relative triiodothyronine deficiency. Most adults with goitrous CH have genetic dyshormonogenesis. They are at high risk of developing thyroid nodules. Our findings support the current guideline recommendation that CH patients with dyshormonogenesis should undergo periodic thyroid ultrasonography.
引用
- Sugisawa C, Narumi S, Tanase-Nakao K, et al. Adult Thyroid Outcomes of Congenital Hypothyroidism. Thyroid. 2023. PMID: 36792927. doi:10.1089/thy.2022.0481
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。